Latest news
Capricor's August 22 FDA Verdict Looms as Stock Sits 89% Below Peak - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 14:44:58 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTReplimune's High-Stakes FDA Verdict: A Biotech Bet Priced for Perfection - AD HOC NEWSAD HOC NEWS · Tue, 04 Aug 2026 16:04:05 GMTGossamer Bio shares surge after FDA filing update; cash concerns and dilution still loom - TechStock²TechStock² · Mon, 27 Jul 2026 07:00:00 GMT